Status:
COMPLETED
Propofol Spinal Procedural Sedation for Cesarean Section
Lead Sponsor:
Mansoura University
Conditions:
Patient Compliance
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Patient's safety and satisfaction are major concerns of anesthesiologists and obstetricians. According to evidence, guidelines and quality markers, regional anesthesia is preferred over general anesth...
Detailed Description
Propofol provides short onset, rapid predictable action, anxiolysis and amnesia and it is more effective than benzodiazepines. Using propofol infusion in low doses during spinal injection in CS did no...
Eligibility Criteria
Inclusion
- Patients scheduled for elective cesarean section,
- Age: 18 - 40 years,
- American Society of Anesthesiologists I - III,
- Patients may present any of the following conditions:
- Respiratory diseases as bronchial asthma
- Hepatic compromise,
- Preeclampsia,
- Anemia with hemoglobin 10 g/dl,
- Previous sections,
- Obese with BMI more than 35%,
- Any criteria of difficult intubation, Compromised fetus as premature delivery, History of complications or non-satisfaction after general anesthesia during previous cesarean section,
Exclusion
- Patients refusing to participate in the study,
- Known psychiatric disease,
- Addiction medications,
- Communication barrier,
- Absolute or relative contraindication for spinal anesthesia,
- Bad obstetric history, complicated pregnancy, congenital fetal anomaly.
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 10 2018
Estimated Enrollment :
228 Patients enrolled
Trial Details
Trial ID
NCT03437980
Start Date
April 1 2018
End Date
September 10 2018
Last Update
September 18 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Delta Hospital
Al Mansurah, Dakahlya, Egypt, 35516
2
Mansoura University Hospital
Al Mansurah, Dakahlya, Egypt, 35516
3
Zagazig University Hospital
Zagazig, Sharkya, Egypt, 44519